BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 18959064)

  • 1. [FOXP1 in B-lymphoproliferative diseases].
    Mara D
    Lijec Vjesn; 2007 May; 129 Suppl 3():43. PubMed ID: 18959064
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical FOXP1 expression in malignant plasma cells that show several simultaneous translocations.
    Korać P; Skrtić A; Peran I; Ventura RA; Dominis M
    Histopathology; 2009 May; 54(6):770-1. PubMed ID: 19438754
    [No Abstract]   [Full Text] [Related]  

  • 3. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
    Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NFkappaB activity in Follicular Lymphoma.
    Green MR; Gandhi MK; Courtney MJ; Marlton P; Griffiths L
    Leuk Res; 2009 Dec; 33(12):1699-702. PubMed ID: 19487025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human FOXP1 isoform 2, using monoclonal antibody 4E3-G11, and intron retention as a tissue-specific mechanism generating a novel FOXP1 isoform.
    Brown PJ; Kagaya R; Banham AH
    Histopathology; 2008 Apr; 52(5):632-7. PubMed ID: 18312343
    [No Abstract]   [Full Text] [Related]  

  • 6. FoxP1: conducting the Hox symphony in spinal motor neurons.
    Arber S
    Nat Neurosci; 2008 Oct; 11(10):1122-4. PubMed ID: 18818591
    [No Abstract]   [Full Text] [Related]  

  • 7. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Korać P; Peran I; Skrtić A; Ajduković R; Kristo DR; Dominis M
    Pathol Int; 2009 May; 59(5):354-8. PubMed ID: 19432679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation.
    Haralambieva E; Adam P; Ventura R; Katzenberger T; Kalla J; Höller S; Hartmann M; Rosenwald A; Greiner A; Muller-Hermelink HK; Banham AH; Ott G
    Leukemia; 2006 Jul; 20(7):1300-3. PubMed ID: 16673020
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical phenotype of a patient with FOXP1 deletion].
    Blanco Sánchez T; Duat Rodríguez A; Cantarín Extremera V; Lapunzina P; Palomares Bralo M; Nevado Blanco J
    An Pediatr (Barc); 2015 Apr; 82(4):280-1. PubMed ID: 25037997
    [No Abstract]   [Full Text] [Related]  

  • 10. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
    Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S
    Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Foxp2-expressing cells in the developing spinal cord.
    Morikawa Y; Hisaoka T; Senba E
    Neuroscience; 2009 Sep; 162(4):1150-62. PubMed ID: 19463901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic bronchopulmonary aspergillosis in a 2-year-old asthmatic boy with immune dysregulation, polyendocrinopathy, enteropathy, X-linked.
    Ohshima M; Futamura M; Kamachi Y; Ito K; Sakamoto T
    Pediatr Pulmonol; 2009 Mar; 44(3):297-9. PubMed ID: 19205054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In search of language genes.
    Nat Neurosci; 2001 Nov; 4(11):1049. PubMed ID: 11687807
    [No Abstract]   [Full Text] [Related]  

  • 14. Talk of genetics and vice versa.
    Pinker S
    Nature; 2001 Oct; 413(6855):465-6. PubMed ID: 11586336
    [No Abstract]   [Full Text] [Related]  

  • 15. FOXP2 as a molecular window into speech and language.
    Fisher SE; Scharff C
    Trends Genet; 2009 Apr; 25(4):166-77. PubMed ID: 19304338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified sound-evoked brainstem potentials in Foxp2 mutant mice.
    Kurt S; Groszer M; Fisher SE; Ehret G
    Brain Res; 2009 Sep; 1289():30-6. PubMed ID: 19596273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-throughput candidate gene mutation screen in lymphoproliferative and myeloproliferative neoplasias.
    Kreil S; Hochhaus A; Cross NC; Chase A
    Leuk Res; 2009 Sep; 33(9):e168-9. PubMed ID: 19464057
    [No Abstract]   [Full Text] [Related]  

  • 18. Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders.
    Musolino C; Allegra A; Penna G; Centorrino R; Cuzzola M; D'Angelo A; Iacopino P; Alonci A
    Acta Haematol; 2009; 122(1):46-9. PubMed ID: 19816006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunodeficiency-associated lymphoproliferative disorders, histiocytic and dendritic cell neoplasms].
    Terui Y
    Rinsho Ketsueki; 2009 Apr; 50(4):271-5. PubMed ID: 19404019
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphoproliferative disorders.
    Young GA
    Pathology; 2005 Dec; 37(6):407-8. PubMed ID: 16373223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.